Last reviewed · How we verify
Reuterin D3 drops
Reuterin D3 drops is a probiotic supplement that contains a combination of beneficial bacteria and vitamin D3.
Reuterin D3 drops is a probiotic supplement that contains a combination of beneficial bacteria and vitamin D3. Used for Supports gut health and immune function.
At a glance
| Generic name | Reuterin D3 drops |
|---|---|
| Also known as | Lactobacillus reuteri DSM 17938 + Vit. D3 |
| Sponsor | University of Campania Luigi Vanvitelli |
| Drug class | Probiotic |
| Modality | Small molecule |
| Therapeutic area | Gastroenterology |
| Phase | Phase 3 |
Mechanism of action
The exact mechanism of action of Reuterin D3 drops is not well established, but it is thought to work by promoting a healthy gut microbiome and supporting immune function. Vitamin D3 is also important for bone health and immune system regulation.
Approved indications
- Supports gut health and immune function
Common side effects
- Gastrointestinal upset
Key clinical trials
- Evaluation of Lactobacillus Reuteri DSM 17938 + Vitamin D3 in the Prevention of RRI in Paediatric Patients (NA)
- Effects of Lactobacillus Reuteri Plus Vitamin D3 in Children With Atopic Dermatitis (NA)
- Lactobacillus Reuteri Versus Placebo in the Treatment and Prevention of Infantile Colic (NA)
- To Evaluate the Efficacy of Supplementation With L. Reuteri + Vit. D3 in Asthmatic Children (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Reuterin D3 drops CI brief — competitive landscape report
- Reuterin D3 drops updates RSS · CI watch RSS
- University of Campania Luigi Vanvitelli portfolio CI